Risk of serotonin syndrome in patients prescribed triptans for migraine, antidepressants - Science Daily

Submitted by Anonymous (not verified) on Wed, 02/28/2018 - 15:56

Risk of serotonin syndrome in patients prescribed triptans for migraine, antidepressantsScience DailyThe FDA issued an advisory in 2006 about the risk of serotonin syndrome associated with concomitant use (at the same time) of triptan antimigraine drugs and selective serotonin reuptake inhibitor (SSRIs) or selective norepinephrine reuptake inhibitor ...